Boston Scientific (BSX) Tops Q3 EPS by 4c; offers guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $48.37 +0.60%
Revenue Growth %: +3.7%
Financial Fact:
Net income (loss) per common share - basic: 0.17
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +3.7%
Financial Fact:
Net income (loss) per common share - basic: 0.17
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $4.21 billion versus the consensus estimate of $4.04 billion.
GUIDANCE:
Boston Scientific sees Q4 2024 EPS of $0.64-$0.66, versus the consensus of $0.64.
Boston Scientific sees FY2024 EPS of $2.45-$2.47, versus the consensus of $2.41.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Matrix Service wins FEED contract for Texas refinery tank farm
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
